SGEN - Seattle Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 512.14B
Enterprise Value 311.84B
Trailing P/E N/A
Forward P/E 1-139.02
PEG Ratio (5 yr expected) 1-2.49
Price/Sales (ttm)16.03
Price/Book (mrq)9.54
Enterprise Value/Revenue 315.63
Enterprise Value/EBITDA 6-57.60

Trading Information

Stock Price History

Beta (3Y Monthly) 1.84
52-Week Change 310.19%
S&P500 52-Week Change 36.70%
52 Week High 384.37
52 Week Low 350.71
50-Day Moving Average 368.88
200-Day Moving Average 370.27

Share Statistics

Avg Vol (3 month) 3865.58k
Avg Vol (10 day) 31.92M
Shares Outstanding 5160.96M
Float 109.72M
% Held by Insiders 11.16%
% Held by Institutions 1106.89%
Shares Short (Jun 28, 2019) 49.73M
Short Ratio (Jun 28, 2019) 414.48
Short % of Float (Jun 28, 2019) 48.97%
Short % of Shares Outstanding (Jun 28, 2019) 46.03%
Shares Short (prior month May 31, 2019) 49.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -36.94%
Operating Margin (ttm)-30.13%

Management Effectiveness

Return on Assets (ttm)-9.06%
Return on Equity (ttm)-21.08%

Income Statement

Revenue (ttm)757.58M
Revenue Per Share (ttm)4.72
Quarterly Revenue Growth (yoy)28.40%
Gross Profit (ttm)1.1M
EBITDA -205.62M
Net Income Avi to Common (ttm)-279.82M
Diluted EPS (ttm)-1.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)376.13M
Total Cash Per Share (mrq)2.33
Total Debt (mrq)79.38M
Total Debt/Equity (mrq)6.24
Current Ratio (mrq)3.03
Book Value Per Share (mrq)7.87

Cash Flow Statement

Operating Cash Flow (ttm)-126.64M
Levered Free Cash Flow (ttm)-66.69M